Biotech executive and scientific leader with deep experience in neuroscience, retinal biology, and the development of therapies for neurodegenerative diseases. I specialize in turning complex scientific concepts into clear strategic plans that advance pipeline programs, strengthen company positioning, and accelerate value creation.